Frank Geller

Title: Frank Geller: Innovator in Genetic Research

Introduction

Frank Geller is a notable inventor based in Seltjarnames, Iceland. He has made significant contributions to the field of genetic research, particularly in understanding susceptibility variants for various diseases. With a total of two patents to his name, Geller's work has the potential to impact risk assessment and management in healthcare.

Latest Patents

Geller's latest patents include "Susceptibility variants for lung cancer" and "Susceptibility variants for peripheral arterial disease and abdominal aortic aneurysm." The first patent discloses certain genetic variants that serve as susceptibility markers for lung cancer. This invention relates to methods of risk assessment using these variants and includes kits designed for risk assessment of lung cancer. The second patent focuses on genetic variants associated with peripheral arterial disease (PAD) and abdominal aortic aneurysm (AAA). It outlines methods for risk management using these variants and also includes kits for risk assessment of PAD and AAA.

Career Highlights

Frank Geller is currently associated with Decode Genetics Ehf, a company known for its pioneering work in genetic research. His role at the company allows him to contribute to groundbreaking studies that aim to improve health outcomes through genetic insights.

Collaborations

Geller has collaborated with notable colleagues such as Thorgeir E Thorgeirsson and Patrick Sulem. These collaborations have likely enhanced the scope and impact of his research in the field of genetics.

Conclusion

Frank Geller's innovative work in genetic research, particularly in identifying susceptibility variants for serious health conditions, showcases his commitment to advancing medical science. His contributions have the potential to significantly influence risk assessment and management in healthcare.